Smokers and nonsmokers had similar symptoms and risk factors present for asthma, but differed in comorbidities.

When patients visiting an allergy/immunology outpatient clinic had expectations met regarding diagnosis and testing, they were more likely to be satisfied with their visit.

Spirometry may be underused for the diagnosis and monitoring of asthma in the primary care setting.

Fractional exhaled nitric oxide, periostin, and eosinophils may help identify patients at increased risk for severe asthma exacerbations, according to a post hoc analysis of a phase 2b trial on dupilumab.

Patients with chronic rhinosinusitis may experience decreases in health-related quality of life comparable to other serious chronic diseases.

Children diagnosed with eczema before the age of 2 years may be at increased risk for early-onset asthma.

Patients with opioid dependence or abuse may exhibit a higher prevalence of asthma compared with the general population.

Results from an online survey show that patients receiving Hizentra were satisfied with treatment.

Tiotropium, when added to standard asthma maintenance therapy, improves lung function in adult patients with symptomatic asthma regardless of GINA asthma severity.

Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 agonists for asthma and chronic obstructive pulmonary disease.

Episodically treating children with recurrent wheezing with inhaled combined salmeterol/fluticasone propionate may be as effective as a daily inhaled fluticasone propionate regimen.

Sputum cultures could aid clinicians in choosing an appropriate antibiotic for patients with cystic fibrosis and avoiding allergies and antibiotic resistance.

Prenatal vitamin D is associated with an increased risk for allergic rhinitis in children born to African American women, but not white women.

Children with asthma who experience chronic oral glucocorticoid exposure may have significant morbidities, including adrenal suppression, recurrent pneumonia, and behavioral problems.

Children who had both parental and sibling asthma in their families had an increased risk for asthma.

Mepolizumab may be effective in patients with asthma that does not respond to omalizumab.

In patients with food allergies but without a history of atopic dermatitis, there was an association of more antibiotic and gastroesophageal reflux medication use.

When testing for sensitivity to histamine, larger swelling sizes were recorded for infants with eczema and atopic dermatitis compared with infants without those conditions.

Researchers investigated whether intravenous reslizumab, a humanized anti-interleukin-5 monoclonal antibody, could aid in the management of asthma and eosinophilia.

Researchers sought to assess the effect of seasonal dose adjustments on the rate of systemic reactions in pediatric patients receiving standardized allergen subcutaneous immunotherapy.

Researchers assessed pooled randomized clinical trial data (NAVIGATE I and II; N5641) to examine the change in SF-36v2 and SF-6D from baseline to the end of double blind and to the end of the studies.

Researchers assessed whether the administration of dupilumab improves signs and symptoms of atopic dermatitis in patients with or without comorbid asthma.

A meta-analysis sought to determine whether prebiotics and probiotics improved the immunogenicity of the flu vaccine in adults.

Reslizumab reduced the risk for exacerbations and improved lung function in patients with severe eosinophilic asthma.

Children who had both parental and sibling asthma in their families had an increased risk for asthma.

A cohort from the CANDLE study was assessed to determine if race plays a role in the protective effect of maternal vitamin D levels on childhood asthma.

Patients with hereditary angioedema experienced a significant reduction in attack rates when treated with lanadelumab.

Although previous studies have demonstrated significant reduction in asthma exacerbations with mepolizumab, investigators sought to assess the medication’s effect on morning peak expiratory flow.

Researchers assessed the use of dupilumab in adults with chronic rhinosinusitis and nasal polyps who did not respond to treatment with intranasal corticosteroids.

Intranasal corticosteroids are the current guideline-preferred treatment recommendation for nasal congestion.